Enliven Therapeutics (ELVN) Return on Invested Capital (2024 - 2025)
Enliven Therapeutics has reported Return on Invested Capital over the past 2 years, most recently at 0.0% for Q2 2025.
- Quarterly results put Return on Invested Capital at 0.0% for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was 0.0% (changed N/A YoY), and the annual figure for FY2024 was 0.0%, changed.
- Return on Invested Capital reached 0.0% in Q2 2025 per ELVN's latest filing, up from 0.0% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.0% in Q2 2025 and bottomed at 0.0% in Q4 2024.